GABAergic deafferentation hypothesis of brain aging and Alzheimer's disease revisited

Brain Research Bulletin

Volumn 45, Issue 4, 1998, Pages 341-379

  Marczynski, Thaddeus J ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Alzheimer's disease; Benzodiazepines; Brain aging; Flumazenil; GABA; Rats

Indexed keywords

4 AMINOBUTYRIC ACID; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; CALCIUM ION; DIAZEPAM; FLUMAZENIL; PENTETRAZOLE;

4 AMINOBUTYRIC ACID RELEASE; ADOLESCENT; AGED; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; BINDING SITE; COGNITION; CONTROLLED STUDY; DEAFFERENTATION; ENZYME SYNTHESIS; EXOCYTOSIS; GABAERGIC TRANSMISSION; HYPOTHESIS; NERVE CELL DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; RETROGRADE NERVE FIBER TRANSPORT; REVIEW;

AGING; ALZHEIMER DISEASE; ANIMALS; BRAIN; GAMMA-AMINOBUTYRIC ACID; HUMANS; NEURONS, AFFERENT; RECEPTORS, GABA;

EID: 0032031815     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(97)00347-X     Document Type: Review

References (318)

1. Ableitner A., Wunster M., Herz A. Specific changes in local glucose utilization in the rat brain induced by acute and chronic diazepam. Brain Res. 359:1985;49-56.
2. Aguayo A. J., Björklund A., Stenevi U., Carlstedt T. Fetal mesencephalic neurons survive and extend long axons across peripheral nervous system grafts inserted into the adult rat striatum. Neurosci. Lett. 45:1984;53-58.
3. Alger B. E., Nicoll R. A. Pharmacologic evidence for two kinds of GABA receptor on rat hippocampal pyramidal cells studied in vitro. J. Physiol. (Lond.). 328:1982;125-130.
4. Allard P. O., Rinne J., Marcusson J. O. Dopamine uptake sites in Parkinson's disease and the dementia of the Alzheimer type. Brain Res. 637:1994;262-266.
5. Anden N. E., Stock G. Inhibitory effect of γ-hydroxybutyric acid and γ-aminobutyric acid on the dopamine cells in the substantia nigra. Naunyn Schmiedeberg's Arch. Pharmacol. 279:1973;89-92.
6. Andersen P., Dingledine R., Gjerstad L., Langmoen I. A., Laursen-Mosfeldt A. Two different responses of hippocampal pyramidal cells to application of gamma-amino butyric acid. J. Physiol. (Lond.). 305:1980;279-296.
7. Antelman S. M., Eichler A. J., Black C. A., Kocan D. Interchangeability of stress and amphetamine in sensitization. Science. 207:1980;329-331.
8. Bachelard H. S. Energy utilized by neurotransmitters. Ingvar D. H., Lassen N. A. Brain work The coupling of function, metabolism and blood flow in the brain; A Benzon symposium VIII . 1975;79-81 Academic Press, New York.
9. Backus K. H., Kettenmann H., Schachner M. Effects of benzodiazepines and pentobarbital on the GABA-induced depolarization in cultured astrocytes. Glia. 1:1988;132-140.
10. Bao J., Cheung W. Y., Wu J.-Y. Brain L-glutamate decarboxylase; inhibition by phosphorylation and activation by dephosphorylation. J. Biol. Chem. 270:1995;6464-6468.
11. Barker J. L., Nicoll R. A. The pharmacology and ionic dependency of amino acid responses in the frog spinal cord. J. Physiol. (Lond.). 228:1973;259-277.
12. Barrett, G. L.; Bartlett, P. F. The p75 nerve growth factor receptor mediates survival or death depending on the stage of sensory neuron development. Proc. Natl. Acad. Sci. USA 91:6501-6005; 1994.
13. Basile A. S., Jones E. A., Skolnick P. The pathogenesis and treatment of hepatic encephalopathy; Evidence for involvement of benzodiazepine receptor ligands. Pharmacol. Rev. 43:1991;27-71.
14. A receptor subunit mRNA in vivo and in vitro. J. Neurochem. 59:1992;62-72.
15. Bayer V. E., Pickel V. M. Ultrastructural localization of tyrosine hydroxylase in the rat ventral tegmental area Relationship between immunolabeling density and neuronal associations . J. Neurosci. 10:1990;2996-3013.
16. Beal M. F., Broulliet E., Jenkins B., Henshaw R., Rosen B., Hyman B. T. Age-dependent striatal excitotoxic lesions produced by the exogenous mitochondrial inhibitor malonate. J. Neurochem. 61:1993;1147-1150.
17. Beal M. F., Hyman B. T., Koroshetz W. Defects in the mitochondrial energy metabolism underlie the pathology of neurodegenerative disease? Trends Neurosci. 16:1993;125-131.
18. Beaulieu C., Samogyi P. Enrichment of cholinergic synaptic terminals on GABAergic neurons and coexistence of immunoreactive GABA and choline acetyltransferase in the same synaptic terminals in the striate cortex of the cat. J. Comp. Neurol. 304:1981;666-680.
19. Behar T. N., Li Y.-X., Tran H. T., Ma W., Dunlap V., Scott C., Barker J. L. GABA stimulates chemotaxis and chemokinesis of embryonic cortical neurons via calcium-dependent mechanisms. J. Neurosci. 16:1996;1808-1818.
20. A receptor expression in axotomized adult sensory neurons. Exp. Neurol. 109:1990;273-278.
21. Black I. B. Environmental regulation of brain trophic interactions. Int. J. Dev. Neurosci. 11:1993;403-410.
22. Black I. B., Adler J. E., Dreyfus C. F., Jonakait G. M., Katz D. M., LaGamma E. F., Markey K. M. Neurotransmitter plasticity at the molecular level. Science. 225:1984;1226-1270.
23. Blass J. P., Zemcov A. Alzheimer's disease. A metabolic system's degeneration? Neurochem. Pathol. 2:1984;103-114.
24. Bliwise D. L., Tinkleberg J., Yesavage J. A., Davies H. REM sleep latency in Alzheimer's disease. Biol. Psychiatry. 25:1989;320-328.
25. Braestrup C. M., Nielsen M. Ontogenic development of benzodiazepine receptors in the rat brain. Brain Res. 147:1978;170-173.
26. Broadhurst P. L. Psychogenetics of emotionality in the rat Experimental approaches to the study of emotional behavior . Ann. NY Acad. Sci. 3:1969;806-824.
27. Calderini G., Bonetti A. C., Aldino A., Savoini G., DiPerr B., Biggio G., Toffano G. Functional interactions between benzodiazepine-GABA recognition sites in aged rats. Neurobiol. Aging. 2:1981;309-313.
28. Carlton P. L. Brain acetycholine and habituation. Prog. Brain. Res. 28:1968;48-60.
29. Cash C. D. Gamma-hydroxybutyrate an overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent . Neurosci. Biobehav. Rev. 18:1994;291-304.
30. Chandrasekaran K., Stoll J., Brady D. R., Rapoport I. Localization of cytochrome oxidase (COX) activity and COX mRNA in the hippocampus and entorhinal cortex of the monkey brain correlation with specific neuronal pathways . Brain Res. 579:1992;333-336.
31. Chandrasekaran K., Stoll J., Giordano T., Atack J. R., Matcha M. F., Brady D. R. Differential expression of cytochrome oxidase (COX) genes in different regions of monkey brain. J. Neurosci. Res. 32:1992;4125-4423.
32. Chao M. V., Hemstead B. L. p75 and Trk A two-receptor system . Trends Neurosci. 18:1995;321-326.
33. Chen Q. X., Stelzer A., Key A. R., Womg R. K. S. GABA receptor function is regulated by phosphorylation in acutely dissociated guinea-pig hippocampal neurons. J. Physiol. (Lond.). 420:1990;204-221.
34. Cheramy A., Leviel V., Glowinski J. Dendritic release of dopamine in the substantia nigra. Nature. 289:1981;537-542.
35. Cherubini E., Gaiarsa J. L., Ben-Ari Y. GABA An excitatory transmitter in early postnatal life . Trends Neurosci. 14:1991;515-519.
36. Choi D. W. Ionic dependence of glutamate neurotoxicity. J. Neurosci. 7:1987;369-379.
37. Coleman D. E., Spring S. R. How G proteins work a continuing story . Trends Biochem. Sci. 21:1996;41-44.
38. Coleman G. L., Barthold S. W., Osbaldiston G. W., Foster S. J., Jones A. M. Pathological changes during aging in barrier-reared Fisher 344 male rats. J. Gerontol. 32:1977;258-278.
39. Collier T., Martin P. N. Schwann cells as a source of neurotrophic activity for dopamine neurons. Exp. Neurol. 124:1993;129-133.
40. Collins M. K. L., Rivas A. L. The control of apoptosis in mammalian cells. Trends Biochem. Sci. 18:1993;307-309.
41. Cooper J. R., Bloom F. E., Roth R. H. The biochemical basis of neuropharmacology, 7th ed. 1995;518 Oxford University Press, New York.
42. Corda M. G., Giorgi O., Mele S., Biggio G. Enhanced sensitivity to β-carboline inverse agonists in rats chronically treated with FG-7142. Brain Res. Bull. 19:1987;379-385.
43. Costa E. H., Guidotti A. Benzodiazepines on trial A research strategy for their rehabilitation . TIPS. 17:1996;192-200.
44. Crutcher K. A., Scott S. A., Liang S., Everson W. V., Weingartner J. Detection of NGF-like activity in human brain tissue Increased levels in Alzheimer's disease . J. Neurosci. 13:1993;2540-2550.
45. Cuello, A. C. Nonclassical neuronal communications. Fed. Proc. 1; 42:2912-2922; 1983.
46. Danguir J. The somatostatin analogue SMD 201-995 promotes paradoxical sleep in aged rats. Neurobiol. Aging. 10:1989;367-4369.
47. Davies C. A., Mann D. M., Sumpter P. Q., Yates P. O. A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J. Neurol. Sci. 78:1987;151-164.
48. Descaries L., Doucet G., Lemay B., Seguela P., Watkins K. C. Structural basis of cortical monoamine function. Avoli M. Neurotransmission and cortical function. 1988;321-332 Plenum Press, New York.
49. Deschenes M., Landry P. Axonal branch diameter and spacing of nodes in the terminal arborization of identified thalamic and cortical neurons. Brain Res. 191:1980;538-544.
50. Engele J., Bohn M. C. The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vivo are mediated by mesencephalic glia. J. Neurosci. 11:1991;3070-3078.
51. Epstein J. L. Anxiolytics, antidepressants and neuroleptics in the treatment of geriatric patients. Lipton M. A., DiMascio A., Killam K. F. Psychopharmacology A generation of progress . 1978;1517-1523 Raven Press, New York.
52. Erdö S. L., Michler A., Wolff J. R. GABA accelerates excitotoxic cell death in cortical cultures Protection by blockers of GABA-gated chloride channels . Brain Res. 542:1991;254-258.
53. Erecinska M., Solver I. A. ATP and brain function. J. Cereb. Blood Flow Metab. 9:1989;2-19.
54. Erlander M. G., Tillakaratne N. J. K., Feldblum S., Patel N., Tobin A. J. Two genes encode distinct glutamate decarboxylases. Neuron. 7:1991;91-100.
55. Esclapez, M.; Houser, C. R. Somatostatin neurons are a subpopulation of GABA neurons in the rat dentate gyrus. Evidence from colocalization of pre-prosomatostatin and glutamate decarboxylase messenger RNAs. Neuroscience 64:339-335; 1995.
56. Ferrarese C., Alho H., Guidotti H., Costa E. Co-localization and co-release of GABA and putative allosteric modulators of GABA receptors. Neuropharmacology. 26:1987;1011-1018.
57. File S. E. The use of social interactions as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J. Neurosci. Methods. 2:1980;219-238.
58. File S. E., Pellow S. Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-17788. Psychopharmacology, (Berlin). 88:1986;1-11.
59. Finch C. E. Neuron atrophy during aging programmed or sporadic? Trends Neurosci. 16:1992;104-110.
60. Fiszman M. L., Novotny E. A., Lange G. D., Barker J. L. Embryonic and early postnatal hippocampal cells respond to nanomolar concentrations of muscimol. Dev. Brain Res. 53:1990;186-193.
61. Fleckenstein A. E., Lookinglabd K. J., Moore K. E. Effects of histamine on 5-hydroxytryptaminergic neuronal activity in the rat hypothalamus. Eur. J. Pharmacol. 264:1994;163-167.
62. Flood J. F., Roberts E. Dehydroepiandrosterone sulfate improves memory in aging mice. Brain Res. 448:1988;178-181.
63. Flood J. F., Morley J. E., Roberts E. Memory enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc. Natl. Acad. Sci. USA. 89:1992;1567-1571.
64. Forchetti C., Meek J. L. Evidence for tonic GABAergic control of serotonin neurons in the median raphe nucleus. Brain Res. 206:1981;208-212.
65. Foster N. L., vanDerspek A. F. L., Aldrich M. S. The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer's disease as measured using positron emission tomography. J. Cereb. Blood Flow Metab. 7:1987;415-420.
66. Foster N. L. PET imaging. Terry R. D. Alzheimer disease. 1994;87-91 Raven Press, New York.
67. Frosch M., Dichter M. A. Non-uniform distribution of GABA activated chloride channels in cultured cortical neurons. Neurosci. Lett. 138:1962;59-62.
68. Fung S. C., Fillenz M. The role of presynaptic GABA and benzodiazepine receptors in the control of noradrenaline release in rat hippocampus. Neurosci. Lett. 42:1983;61-66.
69. Gage F. H., Dunnett S. B., Björklund A. Age related impairments in spatial memory are independent of those in sensorimotor skills. Neurobiol. Aging. 10:1989;347-352.
70. Gaillard J.-M., Blois R. Effect of the benzodiazepine antagonist Ro-1788 on flunitrazepam-induced sleep changes. Br. J. Clin. Pharmacol. 15:1983;529-536.
71. Gallager D. W. Benzodiazepines Potentiation of GABA inhibitory responses in the dorsal raphe nucleus . Eur. J. Pharmacol. 49:1978;133-143.
72. Games D. D., Adams R. Alzheimer type morphology in transgenic mice overexpressing V717 F β-amyloid precursor protein. Nature. 373:1995;523.
73. Gauthier S., Bouchard R., Lamonyagne A. Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease Result of Canadian double blind, crossover, multicenter study . N. Engl. J. Med. 322:1990;1272-1276.
74. Goate A. M., Chartier-Harlin M.-C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., Mant R., Newton P., Rooke K., Roques P., Talbot C., Pericak-Vance M., Roses A., Williamson R., Rossor M., Owen M., Hardy J. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 349:1991;704-706.
75. Gonsalves S. F., Gallager D. W. Persistent reversal of tolerance to anticonvulsant effects and GABAergic subsensitivity by a single exposure to benzodiazepine antagonist during chronic benzodiazepine administration. J. Pharmacol. Exp. Ther. 244:1988;79-83.
76. Gonzales C., Kaufman D. L., Tobin A. J., Chasselet M. F. Distribution of the glutamic acid decarboxylase (M,67,000) in the basal ganglia of the rat An immunohistochemical study with selective cDNA-generated polyclonal antibody . J. Neurocytol. 20:1991;953-961.
77. Grecksch G., deCarvalho L. P., Venault P., Chapouthier G., Rossier J. Convulsions induced by pentylenetetrazol in mice are antagonized by the benzodiazepine antagonist. Ro 15-1788. Life Sci. 32:1983;2579-2584.
78. Greengard P., Valtorta F., Czernik A. J., Benfenati F. Synaptic vesicle phosphoproteins and regulation of synaptic function. Science. 259:1993;780-785.
79. Greif K. F., Erlander M. G., Tillakaratne N. J. K., Tobin A. J. Postnatal expression of glutamate decarboxylases in developing rat cerebellum. Neurochem. Res. 16:1991;235-242.
80. Griffith W. H., Murchison D. A. Enhancement of GABA-activated membrane currents in aged Fischer-344 rat basal forebrain neurons. J. Neurosci. 15:1995;2407-2418.
81. Halasz P. Runs of rapid spikes in sleep: A characteristic EEG expression of generalized malignant epileptic encephalopaties A conceptual review with pharmacological data . Epilepsy Res. Suppl. 2:1991;49-71.
82. Hardy J., Cowburn R., Barton A., Reynolds G., Dodd P., Wester P., O'Carrol A.-M., Lofdahl E., Winblad B. A disorder of GABAergic innervation in Alzheimer's disease. Neurosci. Lett. 73:1987;192-196.
83. Hassler R. Brain mechanisms of intention and attention and other volitional processes. Kornhuber H. H., Deecke L. Motivation, motor and sensory processes of the brain. vol. 54:1980;587-614 Amsterdam, Elsevier.
84. Haydon P. G., Drapeau P. From contact to connection early events during synaptogenesis . Trends Neurosci. 18:1995;196-201.
85. Hedner J. J., Jonason J., Lundberg D. Respiratory effects of gamma-hydroxybutyric acid in anesthetized rats. J. Neurotransm. 49:1980;179-186.
86. Hendry I. A., Stoeckel K., Thoenen H., Iversen L. L. The retrogade transport of nerve growth factor. Brain Res. 68:1974;102-121.
87. Hertz L. Is Alzheimer's disease an anterograde degeneration, originating in the brain stem, and disrupting metabolic and functional interactions between neurons and glia cells? Brain Res. Rev. 14:1989;335-353.
88. Hertz L., Drejer J., Schousboe A. Energy metabolism in glutamatergic neurons, GABAergic neurons and astrocytes in primary cultures. Neurochem. Res. 143:1988;605-610.
89. Herzog C. D., Stackman R. W., Walsh T. J. Intraseptal flumazenil enhances working memory Behavioral and pharmacological specificity . Soc. Neurosci. Abstr. 21:1995;163.
90. Hevner R. F., Wong-Riley T. T. Mitochondrial and nuclear gene expression for cytochrome oxidase subunits are disproportionally regulated by functional activity in neurons. J. Neurosci. 13:1993;1805-1919.
91. +-ATPase . Neurosci. Lett. 138:1992;188-192.
92. Higgitt A., Lader M., Fogany P. The ffects of the benzodiazepine antagonist Ro 15-1788 on psychophysiological performance and subjective measures in normal subjects. Psychopharmacology (Berlin). 89:1986;395-403.
93. Hoch C. C., Reynolds C. F., Nebes R. D., Kupfer D. J. Clinical significance of sleep-disordered breathing in Alzheimer's disease. Am. Geriatr. Soc. 37:1989;138-144.
94. Hoffman, B. F.; Bigger, J. Digitalis and allied cardiac glycosides. In: Goodman and Gilman's The pharmacological basis of therapeutics, 6th ed. New York: MacMillan; 1980:729-760.
95. Hoffman D. W., March M., Giacobini E. Norepinephrine uptake in aging adrenergic nerve terminals. Neurobiol. Aging. 1:1980;65-68.
96. Hollenberg N. K., Graves S. W. The endogenous sodium pump inhibition Current status and therapeutic opportunities . Prog. Drug Res. 46:1996;30-42.
97. Hoyer S., Oesterreich O., Wagner D. Glucose metabolism as the site of the primary abnormality in early onset dementia of Alzheimer's type? J. Neurol. 235:1988;143-148.
98. Hyman C. M., Juhasz C., Jackson P., Wright N., Ip Y., Lindsay R. M. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J. Neurosci. 14:1994;335-347.
99. Iacovitti L. Centrally active differentiation factors in the nervous system. Pharmacol. Ther. 62:1994;373-383.
100. Ihara Y. Massive somato-dendritic sprouting of cortical neurons in Alzheimer's disease. Brain Res. 459:1988;138-144.
101. A receptors to tubulin. J. Neurochem. 63:1994;1119-1125.
102. Izquierdo L., Medina J. H. GABA-A receptor modulation of memory The role of endogenous benzodiazepines . Trends Pharmacol. Sci. 12:1991;260-1265.
103. m, a non-inactivating voltage-depednent outward current blocked by muscarinic agonists. Proc. Natl. Acad. Sci. USA. 85:1988;948-952.
104. Jaffrey S. R., Snyder S. Nitric oxide, a neuromessenger. Annu. Rev. Cell Dev. Biol. 11:1995;417-440.
105. Jahn R., Schiebler W., Quimet C., Greengard P. A 38,000-dalton membrane protein (p38) present in synaptic vesicles. Proc. Natl. Acad. Sci. USA. 82:1985;4137-4141.
106. Kalivas P. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Rev. 18:1993;75-113.
107. Kandel E. R. Environmental determinants of brain architecture and behavior Early experience and learning . Kandel E. R., Schwartz J. H. Principles of neural science. 1981/82;625-632 Elsevier, Amsterdam.
108. Kaneko T., Mizuno N. Glutamate-synthesizing enzymes in GABAergic neurons of the neocortex A double immunofluorescence study in the rat . Neuroscience. 61:1994;839-849.
109. Kapczinski F., Curran V., Gray J., Lader M. Flumazenil has an anxiolytic effect in simulated stress. Psychopharmacology (Berlin). 114:1994;187-189.
110. Kaufman E. E., Driscoll B. E. Carbon dioxide fixation in neuronal and astroglial cells in culture. J. Neurochem. 58:1992;258-262.
111. Kaufman D. L., Houser C. R., Tobin A. J. Two forms of the gamma-amino butyric acid synthetic enzyme glutamate decarboxylase have distict intraneuronal distributions and cofactor interactions. J. Neurochem. 56:1991;720-723.
112. Kellog C. K. Benzodiazepine influences on the developing brain. Prog. Brain Res. 73:1988;207-228.
113. Kerr J. F. R., Harmon B. V. Definition and incidence of apoptosis an historical perspective . Tomei L. D., Cape F. O. Apoptosis The molecular basis of cell death . 1991;5-29 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
114. Kettenmann K.-H., Schachner M. Pharmacological properties of γ-aminobutyric acid, glutamate-, and aspartate-induced depolarizations in cultured astrocytes. J. Neurosci. 5:1985;3295-3301.
115. - channels in cultured astrocytes. Brain Res. 404:1987;1-9.
116. A receptor mRNAs and increases ligand binding. J. Neurochem. 62:1994;2334-2337.
117. Kitt C. A., Price D. L., Struble R. G., Cork L. C., Becher M. W., Weiner B. J., Mobley W. C. Evidence for cholinergic neurites in senile plaques. Science. 226:1984;1443-1445.
118. Kitt C. A., Struble R. G., Cork L. C., Mobley W. C., Walker L. C., Joh T. H., Price D. L. Catecholaminergic neurites in senile plaques in prefrontal cortex of aged nonhuman primates. Neuroscience. 16:1985;691-699.
119. Kocsis J. D., Honmou O. Gabapentin increases GABA-induced depolarization in rat neonatal optic nerve. Neurosci. Lett. 169:1994;1981-1984.
120. Konorski J. Integrative activity of the brain. 1967;100 The University of Chicago Press, Chicago.
121. Korsching S. The neurotrophic factor concept A reexamination . J. Neurosci. 13:1993;2739-2748.
122. Kosaka T., Hataguchi Y., Hama K., Negatsu I., Wuu J.-Y. Coexistence of immunoreactivities for glutamatee decarboxylase and tyrosin hydroxylase in some neurons in the periglomerular region of the rat main olfactory bulb possible coexistence of gamma-aminobutyric acid (GABA) and dopamine . Brain Res. 343:1985;166-171.
123. Kosaka T. K., Tauchi M., Dahl J. L. Cholinergic neurons containing GABA-like and/or glutaminc acid decarboxylase-like immunoreactivities in various brain regions of the rat. Exp. Brain Res. 70:1988;605-617.
124. Kosaka T., Kosaka K., Tateishi K., Hamoaka Y., Yanaihara N., Wu J.-Y., Hama K. GABAergic neurons containing CCK-8-like and/or VIP-like immunoreactivities in the rat hippocampus and dentate gyrus. J. Comp. Neurol. 239:1985;420-430.
125. Kosaka T., Kosaka K., Hataguchi Y., Nagatsu I., Wu J.-Y., Ottersen O. P., Storm-Mathisen J., Hama K. Catecholaminergic neurons containing GABA-like and/or glutamic acid decarboxylase-like immunoreactivities in various brain regions of the rat. Exp. Brain Res. 66:1987;191-210.
126. Lal H., Kumar B., Foster M. J. Enhancement of learning and memory in mice by benzodiazepine antagonist. FASEB J. 2:1988;2707-2711.
127. Lal H., Foster M. J. Flumazenil improves active avoidance performance in aging NZB/BINJ and C57BL/6Nia mice. Pharmacol. Biochem. Behav. 35:1990;747-750.
128. Lamour Y., Dutar P., Rascol O., Jobert A. Basal forebrain neurons projecting to the rat fronto-parietal cortex Electrophysiological and pharmacological properties . Brain Res. 362:1986;122-131.
129. Landfield P. W., Baskin R., Pitler T. Brain aging correlates Retardation by hormonal-pharmacological treatments . Science. 214:1981;581-584.
130. Lannfelt L., Folkesson R., Mohammed A. H., Winblad W., Helgren D., Duff K., Hardy J. Alzheimer's disease Molecular genetics and transgenic animal models . Behav. Brain Res. 57:1993;207-213.
131. Lapidot A., Gopher A. Cerebral metabolic compartmentation. J. Biol. Chem. 269:1994;27198-27208.
132. Lauder J. M., Han V. K. M., Henderson P., Verdoorn T., Towle A. C. Prenatal ontogeny of the GABAergic system in the rat brain An immunocytochemical study . Neuroscience. 19:1986;465-493.
133. A receptor subunit mRNA in the rat brain. III Embryonic and postnatal development . J. Neurosci. 12:1992;4151-4172.
134. Lavie P., Peled R., Wollman M., Zomer J., Tzischinsky O. Agonists-like effects of the benzodiazepine receptor antagonist, Ro 15-1788. Neuropsychobiology. 17:1987;72-76.
135. Lees G. J. Contributing mechanisms in the causation of neurodegenerative disorders. Neuroscience. 54:1993;287-323.
136. Lees G. J., Lehmann A., Sandberg M., Hamberger A. The neurotoxicity of ouabain, a sodium-potassium ATPAse inhibitor, in the rat hippocampus. Neurosci. Lett. 120:1990;159-162.
137. A receptor phosphorylation Multiple sites, actions and artifacts . Trends Pharmacol. Sci. 12:1991;84-87.
138. 13C]-D-glucose metabolism in cultured astrocytes and neurons using nuclear magnetic resonance spectroscopy. Dev. Neurosci. 15:1993;282-288.
139. + and ATP contents of synaptosomes. J. Neurochem. 28:1977;967-975.
140. Lindefors N. Dopaminergic regulation of glutamic acid decarboxylase in the striatum A review . Prog. Neuropsychopharmacol. Biol. Psychiatry. 17:1993;887-903.
141. Lindsay R. M., Wiegand S. J., Altar C. A., DiStefano P. S. Neurotrophic factors From molecule to man . Trends Neurosci. 17:1994;182-190.
142. Linvall G., Cole R. D. Phosphorylation affects the ability of tau to promote microtubule assembly. J. Biol. Chem. 259:1984;7384-7390.
143. Lister R. D., Greenblatt D. J., Abernethy D. R., File S. E. Pharmacokinetic studies on Ro 17-1788, a benzodiazepine receptor ligand in the rat brain. Brain Res. 290:1984;183-186.
144. Livezey G. T., Marczynski T. J., Isaac L. Enduring effects of prenatal diazepam on behavior, EEG and brain receptors of the adult cat progeny. Neurotoxicology. 7:1986;325-340.
145. Livezey G. T., Marczynski T. J., Isaac L. Prenatal diazepam Chronic anxiety and deficits in brain receptors in mature rat progeny . Neurobehav. Toxicol. Teratol. 8:1986;425-432.
146. Livezey G. T., Radulovacki M., Isaac L., Marczynski T. J. Prenatal exposure to diazepam results in enduring reductions in brain receptors and deep slow wave sleep. Brain Res. 334:1985;361-367.
147. Livezey G. T., Marczynski T. J., McGrew E. A., Beluhan F. Z. Prenatal exposure to diazepam late postnatal teratogenic effect . Neuropharmacol. Teratol. 8:1986;433-440.
148. Loewy A. G., Siekevitz P. Cell structure and function. 1963;228 Holt, Rinehart and Winston, Inc, New York.
149. Luebke J. L., Green R. W., Semba K., Kamondi A., McCarley R. W., Reiner P. B. Serotonin hyperpolarizes cholinergic low-threshold burst neurons in the rat latero-dorsal tegmental nucleus in vitro. Proc. Natl. Acad. Sci. USA. 89:1992;743-747.
150. Ma W., Behar T., Maric D., Maric I., Barker J. L. Neuroepithelial cells in the rat spinal cord express glutamate decarboxylase immunoreactivity in vivo and in vitro. J. Comp. Neurol. 325:1992;257-270.
151. A receptor. Neuroscience. 43:1991;369-380.
152. Magistretti P. J., Sorg O., Yu N., Martin J. L., Pellerin L. Neurotransmitters regulate energy metabolism in astrocytes Implications for the metabolic trafficking between neural cells . Dev. Neurosci. 15:1993;36-312.
153. Majewska M. D., Bluet-Pajot M. T., Robel P., Baulieu E. E. Pregnenolone sulfate antagonizes barbiturate-induced sleep. Pharmacol. Biochem. Behav. 33:1989;701-703.
154. A receptor . Prog. Neurobiol. 38:1992;379-395.
155. A receptor. Brain Res. 526:1990;143-146.
156. A receptors and anxiety: From neurobiology to treatment Advances in biochemical psychopharmacology, vol. 48 . 1995;115-133 Raven Press, New York.
157. Mamelak M. Gamma-hydroxybutyrate An endogenous regulator of energy metabolism . Neurosci. Biobehav. Rev. 23:1989;187-198.
158. Mamelak M. Neurodegeneration, sleep and cerebral energy metabolism a testable hypothesis . J. Geriatr. Psychiatr. Neurol. 10:1997;29-32.
159. Manji H. K. G-proteins Implications for psychiatry . Am. J. Psychiatry. 149:1992;746-760.
160. Marczynski T. J. A parsimonious model of mammalian brain revisited. Electroencephalogr. Clin. Neurophysiol. Suppl. 38:1986;343-390.
161. Marczynski T. J. Neurochemical interpretation of cortical slow potentials as they relate to cognitive processes and parsimonious model of mammalian brain. McCallum W. C., Curry S. H. Slow potential changes in the human brain. 1993;253-273 Plenum Press, New York.
162. Marczynski T. J. GABAergic deafferentation hypothesis of brain aging and Alzheimer's disease; Pharmacologic profile of the benzodiazepine antagonist, flumazenil. Rev. Neurosci. 6:1995;221-258.
163. Marczynski T. J., Artwohl J., Marczynska B., Zachary J. F. Chronic administration of flumazenil protects rats from age-related loss of cognitive functions a benzodiazepine/GABAergic hypothesis of brain aging . FASEB J. 7:1993;637.
164. Marczynski T. J., Artwohl J., Marczynska B. Chronic flumazenil protects rats from age-related loss of neurons in the hippocampal formation. FASEB J. 8:1994;657.
165. Marczynski T. J., Artwohl J., Marczynska B. Chronic administration of flumazenil increases life span and protects rats from age-related loss of cognitive functions A benzodiazepine/GABAergic hypothesis of brain aging . Neurobiol. Aging. 15:1994;69-84.
166. Marczynski T. J., Burns L. L., Monley C. A. Empirically derived model of the role of sleep in associative learning and recuperative processes. Neural Networks. 5:1992;371-402.
167. Marczynski T. J., Burns L. L., Vimal R. L. P., Chen E. Sleep and purposive behavior: Inverse deviations from randomness of neuronal firing patterns in the feline thalamus A new form of homeostasis? Brain Res. 298:1984;75-90.
168. Marczynski T. J., Harris C. M., Livezey G. T. The magnitude of EEG postreinforcement synchronization (PRS) in cats reflects learning ability. Brain Res. 204:1981;214-219.
169. Marczynski T. J., Hawkins M. C., Swann P. G., Krivograd A. F., Patel M. K., Dugich M. Perinatal upregulation of benzodiazepine receptor ontogenesis "Fearless" and more efficient goal-directed behavior of adult rat progenies . Neurotoxicol. Teratol. 10:1988;101-111.
170. Marczynski T. J., Urbancic M. Animal models of chronic anxiety and "fearlessness." Brain Res. Bull. 21:1988;483-490.
171. Marczynski T. J., Urbancic M. Chronic flumazenil (Ro 15-1788) facilitates habituation to novel environment and antagonizes scopolamine interference with acquisition of passive avoidance behavior. Soc. Neurosci. Abstr. 17:1991;1047.
172. Marczynski T. J., Urbancic M., Gadek M. Chronic administration of flumazenil (Ro 15-1788) enhances non-appetitive exploratory behavior of rats. Neuropharmacology. 30:1991;1085-1094.
173. Martin D. L. Regulatory properties of brain glutamate decarboxylase. Cell. Mol. Neurobiol. 7:1987;237-253.
174. Martin D. L., Rimvall K. Regulation of gamma-aminobutyric acid synthesis in the brain. J. Neurochem. 60:1993;395-407.
175. Martinez-Rodriguez R., Martinez-Murillo R. Molecular and cellular aspects of neurotransmission and neuromodulation. Int. Rev. Cytol. 149:1994;217-292.
176. Martinez R., Tanda A., Gragera R. R. Synaptic and non-synaptic immunolocalization of GABA and glutamic acid decarboxylase (GAD) in cerebellar cortex of rat. Cell. Mol. Biol. 39:1983;11-23.
177. Masliah E., Hansen L., Albright T., Mallory M., Terry R. D. Immunoelectron microscopic study of synaptic pathology in Alzheimer's disease. Acta Neuropathol. 81:1991;428-433.
178. Masliah E., Mallory M., Hansen L., DeTeresa R., Terry R. D. Quantitative synaptic alterations in the human neocortex during normal aging. Neurology. 43:1993;192-197.
179. Masliah E., Mallory M., Deerinck T., Terry R. D., Carragher B., Ellisman M. Re-evaluation of the structural organization of neuritic plaques in Alzheimer's disease. J. Neuropathol. Exp. Neuropathol. 52:1993;619-632.
180. Masliah E., Mallory M., Hansen L., DeTeresa R., Alford M., Terry R. Synaptic and neuritic alterations during progression of Alzheimer's disease. Neurosci. Lett. 174:1994;67-72.
181. Masliah E., Terry R. D. Role of synaptic pathology in the mechanisms of dementia in Alzheimer's disease. Clin. Neurosci. 1:1993;192-198.
182. Mata M., Fink D. J., Gainer H., Smith C. B., Davidsen L., Savaki H., Schwartz W. J., Sokoloff W. J. Activity-dependent energy metabolism in rat poterior pituitary primarily reflects sodium pump activity. J. Neurochem. 34:1988;213-215.
183. Matsuo E. S., Shin R.-W., Billingsley M. L., van de Voorde A., O'Connor M., Trojanowski J. Q., Lee M.-Y. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron. 3:1994;989-1002.
184. McCauley L. D., Park C. H., Lan N. C., Tomich J. M. Benzodiazepines and peptides stimulate pregnenolone synthesis in brain mitochondria. Eur. J. Pharmacol. 276:1995;145-153.
185. McGilvery, R. W. Biochemistry, 2nd ed. Philadelphia: W. B. Saunders Co.; 1979:862.
186. A receptor subtypes really occur in the brain? Trends Neurosci. 19:1996;139-143.
187. McLemore G. L., Billingsley M. L., Severs W. B. Cardiac noradreneric mechanisms mediate GABA-enhanced ouabain cardiotoxicity. Pharmacology (Berlin). 49:1994;343-350.
188. McNamara D., Howitz B., Grady C. L., Rapoport S. I. Topographical analysis of glucose metabolism, as measured with positron emission tomography in dementia of the Alzheimer's type Use of linear histograms . Int. J. Neurosci. 36:1987;89-97.
189. Medina J. H., Novas M. L., deRobertis E. Changes in benzodiazepine receptors by acute stress Different effects of chronic diazepam or Ro 17-1788 treatment . Eur. J. Pharmacol. 96:1983;181-185.
190. Meguro M.-I., Yanai K., Sakai N., Sukurai E., Maeyama K., Sasaki H., Watanabe T. Effects of thioperamide, a histamine H3 antagonist, on the step-through passive avoidance response and histidine decarboxylase activity in senescence-accelerated mice. Pharmacol. Biochem. Behav. 50:1995;321-325.
191. Meier E., Belhage B., Drejer J., Schousboe A. The expression of GABA receptors on cultured cerebellar granule cells is influenced by GABA. Redburn D. A., Schousboe A. Neurology and neurobiology, vol. 32, Neurotrophic activity of GABA during development. 1987;139-160 Liss, New York.
192. Meier E. J., Drejer J., Schousboe A. Trophic actions of GABA on the development of physiologically active GABA receptors. Mandel P. M., Feudis F. V. CNS receptors; From molecular pharmacology to behavior. 1983;47-53 Raven Press, New York.
193. Meisler A., Anderson M. E. Glutathione. Annu. Rev. Biochem. 52:1983;711-760.
194. Memo M., Spano P. F., Trabuchi M. Brain benzodiazepine receptor changes during ageing. J. Pharm. Pharmacol. 33:1981;64.
195. Mendelson M. B. Human sleep. 1987;213 Plenum, New York.
196. Meyers M. B., Komyskey H. L. Aging Effect on the interaction of ethanol and pentobarbital with the benzodiazepine-GABA receptor ionophore complex . Brain Res. 342:1985;262-267.
197. A receptor subunit mRNA levels in Fisher rats. Mol. Brain Res. 14:1992;71-78.
198. A receptor β-subunit. Brain Res. 23:1994;246-248.
199. A receptors in the hippocampus. Science. 253:1991;1420-1423.
200. Miller L. P., Walters J. R. Effect of depolarization on cofactor regulation of glutamic acid decarboxylase in substantia nigra synaptosomes. J. Neurochem. 33:1979;533-539.
201. Mizoguchi K., Kunishita T., Chui D., Tabira T. Stress induces neuronal death in the hippocampus of catrated rats. Neurosci. Lett. 138:1992;157-161.
202. Mogenson G. J., Jones D. L., Yim C. Y. From motivation to action Functional interface between the limbic system and the motor system . Prog. Neurobiol. 14:1980;69-97.
203. Möhler H., Burkhard W. P., Keller H. H., Richards J. G., Haefely W. Benzodiazepine antgonist Ro 15-1788 Binding characteristics and interaction with drug-induced changes in dopamine turnover and cerebellar cGMP levels . J. Neurochem. 37:1980;714-722.
204. Montero, C. N.; Hefti, F. Intraventricular nerve growth factor administration prevents lesion-induced loss of septal cholinergic neurons in aging rats. Neurobiol. Aging 10:739-743; 1089.
205. Moodley P., Golombok S., Shine P., Lader M. Computed axial brain tomograms in long-term benzodiazepine users. Psychiatr. Res. 48:1993;135-144.
206. Moore R. Y., Bloom F. E. Central catecholamine neuron system Anatomy and physiology of the norepinephrine and epinephrine systems . Neuroscience. 2:1978;113-168.
207. Mucke L., Masliah E., Johnson W. B., Ruppe M. D., Alford M., Rockenstein E. M., Forss-Petter S., Pietropaolo M., Mallory M., Abraham C. R. Synaptotrophic effects of human amyloid β-protein precursors in the cortex of transgenic mice. Brain Res. 666:1994;151-167.
208. Murrell J., Farlow M., Ghetti B., Benson M. D. A mutation in the amyloid precursor protein associated with hereditatry Alzheimer's disease. Science. 254:1991;97-99.
209. Murphy T. H., Myiamoto M., Sastre A., Schnaar R. L., Coyle J. T. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxydative stress. Neuron. 2:1989;1547-1558.
210. Näsman B., Olsson T., Bäckström T., Eriksson S., Grankvist K., Viitanen M., Bucht G. Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia. Biol. Psychiatry. 30:1991;684-690.
211. Nathan B., Bao J., Hsu C.-C., Yarom M., Deupree D. L., Lee Yi. H., Tang X. W., Kuo C. Y., Burghen G. A., Wu J. Y. An integral membrane protein form of brain L-glutamate decarboxylase Purification, characterization and its relationship to insulin-dependent diabetes mellitus . Brain Res. 642:1994;297-302.
212. Nathan B., Hsu C. H., Bao J., Wu R., Wu J. Y. Purification and characterization of a novel form of brain L-glutamate decarboxylase. J. Biol. Chem. 269:1994;7249-7254.
213. Nicoll R. A., Malenka R. C., Kauer J. A. Functional comparison of neurotransmitter receptor subtypes in mammalian central nervous system. Physiol. Rev. 70:1990;513-553.
214. Niecoullon A., Cheramy A., Glowinski J. Release of dopamine in vivo from cat substantia nigra. Nature. 266:1977;375-377.
215. Nordberg A., Lilja A., Lundquist H., Hartvig P., Amberla K., Viitanen M., Warman U., Johansson M., Hellström-Lindahl E., Bjurling P., Fasth K.-J., Langström;, Winblad B. Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography. Neurobiol. Aging. 13:1992;747-758.
216. Novelli A., Reilly J. A., Lysko P. G., Henneberry R. C. Glutamate becomes neurotoxic via N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res. 451:1988;205-212.
217. Oberg R. G., Divac I. Levels of motor planning, cognition and control of movements. Trends Neurosci. 4:1981;122-124.
218. Ochi S., Lim J. Y., Rand M. N., During M. J., Sakatani K., Kocsis J. D. Transient presence of GABA in astrocytes of the developing optic nerve. Glia. 9:1993;188-198.
219. O'Connor S. D., Urbancic M., Marczynski T. J., Radulovacki M. Chronic Ro 15-1788 treatment increases REM sleep in rats. Brain Res. Bull. 27:1991;251-253.
220. Okazaki H., Tokuda H., Ishii K., Ishibashi S. Barbiturates suppress glucose utilization by inhibition of hexokinase in neuroblastoma cells. Biochem. Biophys. Res. Commun. 184:1992;673-679.
221. Olney J. W., Ho O. L., Rhe V. Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system. Exp. Brain Res. 14:1971;61-76.
222. A receptors. FASEB J. 4:1990;1469-1480.
223. O'Malley D. M., Sandell J. H., Masland R. H. Co-release of acetylcholine and GABA by the starburst amacrine cells. J. Neurosci. 12:1992;1394-1408.
224. Osmanovic S. S., Shefner S. Gamma-aminobutyric acid responses in rat locus coeruleus neurons in vitro A current-clamp and voltage-clump study . J. Physiol. 421:1990;151-170.
225. Osorio I., Davidoff R. Gamma-hydroxybutyrate acid is not a GABA-mimetic agent in the spinal cord. Ann. Neurol. 6:1979;111-116.
226. 2-fixing enzymes in the metabolism of rat brain. J. Neurochem. 22:1974;717-724.
227. Paul S. M., Purdy R. H. Neuroactive steroids. FASEB J. 6:1992;2311-2322.
228. Pavlides C., Winson J. Influences of hippocampal place cell firing in the awake state on the activity of these cells during subsequent sleep in rats. J. Neurosci. 9:1989;2907-2918.
229. Paxinos G., Watson C. Stereotaxic atlas of the rat brain. 1982;Academic Press, Sydney.
230. Perry R. H., Candy J. M., Perry E. K., Irving D., Blessed G., Fairkirn A. F., Tomlison B. E. Extensive loss of choline acetytransferase activity is regulated by neuronal loss in the nucleus of Meynert in Alzheimer's disease. Neurosci. Lett. 33:1982;311-315.
231. Pirozzolo F. J., Hansch E. C., Mortimer J. A., Webster D. D., Kuskowski M. A. Dementia in Parkinson disease A neuropsychological analysis . Brain Cogn. 1:1982;17-83.
232. A receptor subunit for benzodiazepine pharmacology. Nature. 338:1989;582-585.
233. Rabizadeh S., Oh J., Zhong L. T., Yang J. Induction of apoptosis by the low-affinity NGF receptor. Science. 261:1993;345-348.
234. Rapaske D. R., Corbin J. G., Conti M., Goy M. F. A cyclic GMP-stimulated cyclic nucleotide phosphodiesterase gene is highly expressed in the limbic system of the rat brain. Neuroscience. 56:1993;673-686.
235. Ratan R. R., Murphy T. H., Baraban J. M. Oxidative stress induces apoptosis in embryonic cortical neurons. J. Neurochem. 62:1994;376-379.
236. Reinikainen K. J., Piliarvi L., Huuskonen M., Soinen H., Laakso M., Riekkinen P. J. A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease. J. Neurol. Sci. 84:1988;101-116.
237. Reubi J., Iversen L. L., Jessel T. M. Dopamine selectively increases GABA release from slices of rat substantia nigra in vitro. Nature. 266:1977;652-654.
238. Richards J. G., Burghard W. P., Lorenz H. P., Moehler H. Preclinical research findings with flumazenil (Ro 15-1788) Biochemistry and cytopharmacology . Eur. J. Anaesthesiol. 5:(Suppl. 2):1988;39-45.
239. Rimvall K., Martin D. L. The level of GAD67 protein is highly sensitive to small increases in intraneuronal γ-aminobutyric acid levels. J. Neurochem. 62:1994;1375-1381.
240. Risold P. Y., Swanson L. W. Structural evidence for functional domains in the rat hippocampus. Science. 272:1996;1484-1486.
241. Roberts E. Some thoughts about GABA and the basal ganglia. Yahr M. D. The basal ganglia. 1976;191-203 Raven Press, New York.
242. Roberts E. What do GABA neurons really do? They make possible variability generation in relation to demand. J. Mind Behav. 8:1987;591-604.
243. Roberts E., Frankel S. Glutamic acid decarboxylase in brain. J. Biol. Chem. 188:1950;789-795.
244. Roberts E., Bologa L., Flood J. F., Smith G. E. Effects of dehydroepiandrosterone and its sulfate on brain tissue in culture and on memory in mice. Brain Res. 406:1987;357-362.
245. Rossor M. N. Parkinson's disease and Alzheimer's disease as disorders of the isodendritic core. Br. Med. J. 283:1981;1588-1590.
246. Rothman S. M. Neurotoxicity of excitatory amino acids is produced by passive chloride influx. J. Neurosci. 5:1985;1483-1489.
247. Rothstein J. D., Garland W., Puia G., Guidotti A., Weber R., Costa E. Purification and characterization of naturally occurring benzodiazepine receptor ligands. J. Neurochem. 58:1992;2102-2115.
248. Rothstein J. D., Guidotti A., Tinuper P., Cortelli P., Avoni G., Plazzi E., Lugaresi P., Schoch P., Montagna P. Endogenous benzodiazepine receptor ligands in idiopathic recurring stupor. Lancet. 340:1992;1002-1004.
249. A receptors in developing rat optic nerve. Proc. R. Soc. Lond. B. 247:1992;155-161.
250. Santucci A. C., Kanof P. D., Haroutunian V. Cholinergic marker deficits induced by lesions of the nucleus basalis of Meynert are attenuated by nerve growth factor in young but not in aged, F344 rats. Brain Res. 609:1993;327-332.
251. Sapolsky R. M. Potential behavioral modification of glucocorticoid damage to the hippocampus. Behav. Brain Res. 57:1993;175-182.
252. Sarter M., Stephens D. N. β-Carbolines as tools in memory research Animal data and speculations . Hindmarch I., Ott H. Benzodiazepine receptor ligands, memory and information processing. 1988;230-245 Springer, Berlin.
253. Savic I., Widen L., Stone-Erlander S. Feasibility of reversing benzodiazepine tolerance with flumazenil. Lancet. 337:1991;133-137.
254. Schmauss C., Krieg J. C. Enlargement of cerebrospinal fluid spaces in long-term benzodiazepine abusers. Psychol. Med. 17:1987;869-873.
255. Schmechel D. E., Vicray B. G., Fitzpatrick D., Elde R. P. GABAergic neurons of mammalian crebral cortex; widespread subclass defined by somatostatin content. Neurosci. Lett. 47:1984;227-232.
256. Schöpf J., Lurian S., Le P. K., Gaillard J. M. Intrinsic activity of the benzodiazepine antagonist Ro 15-1788 in man An electrophysiological investigation . Pharmacopsychiatry. 17:1984;79-83.
257. Scollo-Lavizzari G. The clinical anticonvulsant effects of flumazenil, a benzodiazepine antagonist. Eur. J. Anaestesiol. Suppl. 2:1988;129-138.
258. Segovia J., Castro R., Notario R., Gale K. Transplants of fetal substantia nigra regulate glutaminc acid decarboxylase gene expression in host striatal neurons. Mol. Brain Res. 10:1991;359-362.
259. Seligmann B., Miller L. P., Brockman D. E., Martin D. L. Studies on the regulation of GABA synthesis The interaction of adenin nuleotides and glutamate with brain glutamate decarboxylase . J. Neurochem. 30:1978;371-376.
260. Seroogy K. B., Gall C. M. Expression of neurotrophins by midbrain dopaminergic neurons. Exp. Neurol. 14:1993;119-128.
261. Shepherd G. M. Neurobiology, 2nd ed. 1988;689 Oxford University Press, New York.
262. A receptor subunits exist in distict neuronal subpopulations. Neuron. 3:1989;327-337.
263. A receptors on channel function. Neuron. 5:1990;703-711.
264. Simmonds M. A. Depolarizing responses to glycine, β-alanine and muscimol in isolated optic nerve and cuneate nucleus. Br. J. Pharmacol. 79:1983;799-806.
265. Simmons R. D., Miller R. K., Kellog C. K. Prenatal exposure to diazepam alters central and peripheral responses to stress in adult offspring. Brain Res. 307:1984;39-46.
266. Simonian N. A., Hyman B. T. Functional alterations in neuronal circuits in Alzheimer's disease. Neurobiol. Aging. 16:1995;305-309.
267. Simpson M. D. C., Cross A. J., Slater P., Deakin J. F. W. Loss of cortical GABA uptake sites in Alzheimer's disease. J. Neural Transm. 71:1988;219-226.
268. Sims N. R., Bowen D. M., Allen S. J., Smith C. C., Neary D., Thomas D. J., Davison A. M. Presynaptic cholinergic dysfunction in patients with dementia. J. Neurochem. 40:1983;503-509.
269. Skou J. C. Enzymatic basis for active transport of sodium and potassium across cell membranes. Physiol. Rev. 45:1965;596-617.
270. Smith C. Sleep states and learning; A review of animal literature. Neurosci. Biobehav. Rev. 9:1985;157-168.
271. Smith S. E., Sharp T. An investigation of the origin of extracellular GABA in rat nucleus accumbens measured in vivo by microdialysis. J. Neural Transm. Gen. Sect. 97:1994;161-171.
272. Snead O. C. III, Liu C.-C. Gamma-hydroxybutyric acid binding sites in rat and human brain synaptosomal membranes. Biochem. Pharmacol. 33:1984;2587-2590.
273. +) nigral toxicity in the rat by prior decortication or MK-801 treatment A stereological estimate of neuronal loss . Neurobiol. Aging. 14:1993;295-301.
274. Stackman R. W., Walsh T. J. Chlordiazepoxide-induced working memory impairment Site specificity and reversal by flumazenil (Ro 15-1788) . Behav. Neural. Biol. 57:1992;223-243.
275. Stackman R. W., Walsh T. J. Anatomical specificity and time-dependence of chlordiazepoxide-induced spatial memory impairments. Behav. Neurosci. 109:1995;436-445.
276. Staley K. J., Saldo B. L., Proctor W. R. Ionic mechanisms of neuronal excitation by inhibitory GABA receptors. Science. 269:1995;928-929.
277. Struble R. G., Kitt C. R., Walker L. C., Cork L. C., Price D. L. Somatostatinergic neurites in senile plaques of aged non-human primates. Brain Res. 324:1984;394-396.
278. 14C]glucose in hippocampal slices Effect of depolarization . Brain Res. 293:1984;293-303.
279. Taberner P. V., Rick J. T., Kerkut G. A. The action of gamma-hydroxybutyric acid on cerebral glucose metabolism. J. Neurochem. 19:1972;245-254.
280. Takeda N., Inagaki S., Shiosaka S., Taguchi Y., Oertel W. H., Tohyama M., Watanabe T., Wada H. Immunohistochemical evidence for the coexistence of histidine decarboxylase-like and glutamate decarboxylase-like immunoreactivities in nerve cells of the magnocellular nucleus of the posterior hypothalamus of rats. Proc. Natl. Acad. Sci. USA. 81:1984;7647-7650.
281. Terry R. D., Katzman R. Senile dementia of the Alzheimer type. Ann. Neurol. 14:1983;497-506.
282. Terry R. D., Hansen L. A., DeTeresa R., Davies P., Tobias H., Katzman R. Senile dementia of the Alzheimer's type without neocortical neurofibrillary tangles. J. Neuropathol. Exp. Neurol. 46:1987;262-268.
283. Terry R. D., Masliah E., Salmon D. P., Butters D. P., DeTeresa N., Hill R., Hansen L. A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30:1991;572-580.
284. Ticku M. Benzodiazepine - GABA receptor-ionophore complex. Neuropharmacology. 22:1983;1459-1470.
285. Trullas R., Havoundian H., Zamir N., Paul S., Skolnick P. Environmentally-induced modification of the benzodiazepine/GABA receptor coupled chloride ionophore. Psychopharmacology (Berlin). 91:1987;384-390.
286. Tursky T. Inhibition of brain glutamate decarboxylase by adenine triphosphate. Eur. J. Biochem. 12:1970;544-549.
287. Urbancic M., Gadek M., Marczynski T. J. Chronic exposure to flumazenil Anxiolytic effect and increased exploratory behavior . Pharmacol. Biochem. Behav. 35:1990;503-509.
288. Urbancic M., Marczynski T. J. Chronic exposure to Ro 15-1788 Differential effect on flunitrazepam binding to cortex and hippocampus . Eur. J. Pharmacol. 171:1989;1-7.
289. Urbancic M., Gadek M., Marczynski T. J. Chronic flumazenil (Ro15-1788) facilitates acquisition and retention of a swim-escape response in rats. Neuropsychobiology. 24:1990/91;17-24.
290. A receptors. Mol. Brain Res. 31:1995;165-172.
291. Vanhala A., Yamatodani A., Panula P. Distribution of histamine-, 5-hydroxytryptamine-, and tyrosine hydroxylase-immunoreactive neurons and nerve fibers in developing rat brain. J. Comp. Neurol. 347:1994;101-114.
292. Van Hoesen G. W., Benjamin D., Affifi A. K. Limbic cortical input to area 6 in the monkey. Anat. Rec. 199:1981;262A.
293. A receptors depend upon subunit composition. Neuron. 4:1990;919-928.
294. Vern B., Hubbard J. I. Reinvestigation of the effects of gamma-hydroxybutyrate on the sleep cycle of the unrestrained intact cat. Electroencephalalogr. Clin. Neurophysiol. 6:1971;573-580.
295. Vitiello M. V., Prinz P. N. Alzheimer's disease Sleep and wake patterns . Clin. Geriatr. Med. 5:1989;289-299.
296. Walaas S. I., Jahn R., Greengard P. Quantitation of nerve terminal population Synaptic vesicle associated protein density in the rat neostriatum . Synapse. 2:1988;516-520.
297. Wallace W., Haroutunian V. Using the subcortically lesioned rat cortex to understand the physiological role of amyloid precursor protein. Behav. Brain Res. 57:1993;199-206.
298. Wallace W. C., Ahlers S. T., Gotlib J., Bragin V., Sugar J., Gluck R., Shea P. A., Davis K. L., Haroutunian V. Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation. Proc. Natl. Acad. Sci. USA. 90:1993;8712-8716.
299. Walsh T. J., Stackman R. W., Emerich D. F., Taylor L. A. Intraseptal injections of GABA and benzodiazepine receptor ligands alters high-affinity choline transport in the hippocampus. Brain Res. Bull. 31:1993;267-271.
300. Wauqier A., Ashton D. The benzodiazepine antagonist, Ro 15-1788, increases REM and slow wave sleep in the dog. Brain Res. 308:1984;159-161.
301. Waxman S. G., Black J. A., Kocsis J. D., Ritchie J. M. Low density of sodium channels supports action potential conduction in asxons of neonatal rat optic nerve. Proc. Natl. Acad. Sci. USA. 86:1989;1406-1410.
302. West M. J., Gundersen H. J. G. Unbiased stereological estimation of number of neurons in the human hippocampus. J. Comp. Neurol. 296:1990;1-22.
303. White G. GABA receptor-activated current in dorsal root ganglion neurons, freshly isolated from adult rats. J. Neurophysiol. 64:1990;57-63.
304. White, A.; Handler, P.; Smith, E. L. Principles of biochemistry. New York: McGraw-Hill Book Company; 1959:1106.
305. Wiedenmann B., Franke W. W. Identification and localization of synaptophysin and integral membrane glycoprotein of Mr 38,00 characteristic of presynaptic vesicles. Cell. 45:1985;1017-1028.
306. Williams K. Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptor by histamine. Mol. Pharmacol. 46:1994;531-541.
307. Williams G. V., Goldman-Rakic P. S. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature. 376:1995;572-575.
308. Wilson M. A., McNaughton B. L. Reactivation of hippocampal ensemble memories during sleep. Science. 265:1994;676-679.
309. Wolfman C., Da Cunha C., Jerusalinsky D., Levi de Stein M., Viola H., Izquierdo I., Medina J. H. Habituation and inhibitory avoidance training alter brain regional levels of benzodiazepine-like molecules and are affected by intracerebral flumazenil microinjection. Brain Res. 548:1991;74-80.
310. Woody C. D., Gruen E. Evidence that acetylcholine acts in vivo in layer V pyramidal cells of cats via cGMP and cGMP-dependent protein kinase to produce a decrease in outward current. Avoli M., Reader T. A., Dykes R. W., Gloor P. Neurotransmitter and neuronal function, from molecules to mind. 1988;313-319 Plenum, New York.
311. Woolf N. J. Cholinergic systems in mammalian brain and spinal cord. Prog. Neurobiol. 37:1991;475-524.
312. Yamatsuji T., Matsui T., Okamoto T., Komatsuzaki K., Takeda S., Fukumoto H., Iwatsubo T., Suzuki N., Asami-Odaka A., Ireland S. G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP. Science. 272:1996;1349-1352.
313. Zaborszky L., Cullinan W. E., Luine V. N. Catecholaminergic-cholinergic interaction in the basal forebrain. Prog. Brain Res. 98:1993;31-49.
314. Zaborszky L., Heimer L., Eckenstein F., Leranth C. GABAergic input to cholinergic forebrain neurons An ultrastructural study using retrograde tracing of HRP and double immunolabelling . J. Comp. Neurol. 250:1986;282-295.
315. 3H]-flunitrazepam binding site during postnatal development of the mouse cerebellum. Dev. Brain Res. 61:1991;63-71.
316. Zhang S. J., Jackson M. B. GABA-activated chloride channels in secretory nerve endings. Science. 259:1993;531-534.
317. Zigmond M. J., Stricker E. M. Animal models of Parkinsonism using selective neurotoxins Clinical and basic implications . Int. Rev. Neurobiol. 31:1989;1-79.
318. Zucco G. M., Negrin N. S. Olfactory deficits in Down subjects A link with Alzheimer's disease? Percept. Mot. Skills. 78:1994;627-631.